NCT01681524View on ClinicalTrials.gov

Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

May 31, 2014

Conditions
Coronary Artery Disease
Interventions
DRUG

Flurpiridaz F18

Injection of Flurpiridaz F18 for the purposes of PET MPI analysis

Sponsors
All Listed Sponsors
lead

Lantheus Medical Imaging

INDUSTRY